MAM
RLAY icon

Martingale Asset Management’s Relay Therapeutics RLAY Stock Holding History

Martingale Asset Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-80,371
Closed -$211K – 846
2025
Q1 		$211K Hold
80,371
– – 0.01% 737
2024
Q4 		$331K Buy
80,371
+2,700
+3% +$14.7K 0.01% 674
2024
Q3 		$550K Buy
77,671
+700
+0.9% +$5.23K 0.01% 609
2024
Q2 		$502K Buy
76,971
+19,145
+33% +$131K 0.01% 596
2024
Q1 		$480K Buy
57,826
+11,130
+24% +$109K 0.01% 626
2023
Q4 		$514K Buy
46,696
+17,330
+59% +$146K 0.01% 610
2023
Q3 		$247K Buy
+29,366
New +$316K 0.01% 719

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Martingale Asset Management's RLAY Position: Q2 2025 in Review

Martingale Asset Management sold out of Relay Therapeutics (RLAY) in Q2 2025, closing a stake of 80,371 shares — an estimated $211K sold.

Martingale Asset Management first reported a position in RLAY in Q3 2023 and held it in 7 quarters. The position peaked at $550K in Q3 2024. 208 funds tracked by Wall St. Rank hold RLAY as of Q2 2025.

  • Martingale Asset Management reported no remaining Relay Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Martingale Asset Management sold 80,371 Relay Therapeutics shares in Q2 2025, an estimated $211K.
  • Martingale Asset Management first reported a position in Relay Therapeutics in Q3 2023 and held it in 7 quarters.
  • Martingale Asset Management's Relay Therapeutics position peaked at $550K in Q3 2024.
  • 208 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2025.

Based on Martingale Asset Management's 13F filing for Q2 2025, filed 11 Aug 2025.